BRPI0811140A2 - processos melhorados para produção de hidrazidas - Google Patents

processos melhorados para produção de hidrazidas

Info

Publication number
BRPI0811140A2
BRPI0811140A2 BRPI0811140A BRPI0811140A BRPI0811140A2 BR PI0811140 A2 BRPI0811140 A2 BR PI0811140A2 BR PI0811140 A BRPI0811140 A BR PI0811140A BR PI0811140 A BRPI0811140 A BR PI0811140A BR PI0811140 A2 BRPI0811140 A2 BR PI0811140A2
Authority
BR
Brazil
Prior art keywords
improved processes
hydrazide
production
hydrazide production
processes
Prior art date
Application number
BRPI0811140A
Other languages
English (en)
Inventor
Ayman Sahli
George A Chiarello
Original Assignee
Wyeth Llc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Wyeth Llc filed Critical Wyeth Llc
Publication of BRPI0811140A2 publication Critical patent/BRPI0811140A2/pt
Publication of BRPI0811140B1 publication Critical patent/BRPI0811140B1/pt

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C319/00Preparation of thiols, sulfides, hydropolysulfides or polysulfides
    • C07C319/14Preparation of thiols, sulfides, hydropolysulfides or polysulfides of sulfides
    • C07C319/20Preparation of thiols, sulfides, hydropolysulfides or polysulfides of sulfides by reactions not involving the formation of sulfide groups
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C323/00Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups
    • C07C323/23Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and nitrogen atoms, not being part of nitro or nitroso groups, bound to the same carbon skeleton
    • C07C323/46Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and nitrogen atoms, not being part of nitro or nitroso groups, bound to the same carbon skeleton having at least one of the nitrogen atoms, not being part of nitro or nitroso groups, further bound to other hetero atoms
    • C07C323/48Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and nitrogen atoms, not being part of nitro or nitroso groups, bound to the same carbon skeleton having at least one of the nitrogen atoms, not being part of nitro or nitroso groups, further bound to other hetero atoms to nitrogen atoms
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/51Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
    • A61K47/68Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an antibody, an immunoglobulin or a fragment thereof, e.g. an Fc-fragment
    • A61K47/6889Conjugates wherein the antibody being the modifying agent and wherein the linker, binder or spacer confers particular properties to the conjugates, e.g. peptidic enzyme-labile linkers or acid-labile linkers, providing for an acid-labile immuno conjugate wherein the drug may be released from its antibody conjugated part in an acidic, e.g. tumoural or environment
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C241/00Preparation of compounds containing chains of nitrogen atoms singly-bound to each other, e.g. hydrazines, triazanes
    • C07C241/04Preparation of hydrazides
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C243/00Compounds containing chains of nitrogen atoms singly-bound to each other, e.g. hydrazines, triazanes
    • C07C243/24Hydrazines having nitrogen atoms of hydrazine groups acylated by carboxylic acids
    • C07C243/26Hydrazines having nitrogen atoms of hydrazine groups acylated by carboxylic acids with acylating carboxyl groups bound to hydrogen atoms or to acyclic carbon atoms
    • C07C243/28Hydrazines having nitrogen atoms of hydrazine groups acylated by carboxylic acids with acylating carboxyl groups bound to hydrogen atoms or to acyclic carbon atoms to hydrogen atoms or to carbon atoms of a saturated carbon skeleton
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C319/00Preparation of thiols, sulfides, hydropolysulfides or polysulfides
    • C07C319/02Preparation of thiols, sulfides, hydropolysulfides or polysulfides of thiols
    • C07C319/12Preparation of thiols, sulfides, hydropolysulfides or polysulfides of thiols by reactions not involving the formation of mercapto groups
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02PCLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00Technologies relating to chemical industry
    • Y02P20/50Improvements relating to the production of bulk chemicals
    • Y02P20/55Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Immunology (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Coating Apparatus (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
BRPI0811140-5A 2007-05-22 2008-05-20 Processos melhorados para produção de hidrazidas BRPI0811140B1 (pt)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US93952907P 2007-05-22 2007-05-22
US60/939.529 2007-05-22
PCT/US2008/064213 WO2008147765A1 (en) 2007-05-22 2008-05-20 Improved processes for making hydrazides

Publications (2)

Publication Number Publication Date
BRPI0811140A2 true BRPI0811140A2 (pt) 2015-10-27
BRPI0811140B1 BRPI0811140B1 (pt) 2022-08-16

Family

ID=39810161

Family Applications (1)

Application Number Title Priority Date Filing Date
BRPI0811140-5A BRPI0811140B1 (pt) 2007-05-22 2008-05-20 Processos melhorados para produção de hidrazidas

Country Status (24)

Country Link
US (5) US8110705B2 (pt)
EP (2) EP2465541B1 (pt)
JP (4) JP5697446B2 (pt)
KR (1) KR101547705B1 (pt)
CN (2) CN101835494B (pt)
AR (1) AR066674A1 (pt)
AU (1) AU2008256905B2 (pt)
BR (1) BRPI0811140B1 (pt)
CA (1) CA2687852A1 (pt)
CL (1) CL2008001490A1 (pt)
CY (2) CY1119373T1 (pt)
DK (2) DK2155258T3 (pt)
ES (2) ES2642888T3 (pt)
HU (2) HUE039657T2 (pt)
IL (1) IL202242A (pt)
MX (1) MX2009012587A (pt)
PA (1) PA8781201A1 (pt)
PE (1) PE20090305A1 (pt)
PL (2) PL2465541T3 (pt)
PT (2) PT2155258T (pt)
SI (2) SI2155258T1 (pt)
TW (1) TW200904784A (pt)
WO (1) WO2008147765A1 (pt)
ZA (1) ZA200908229B (pt)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2687852A1 (en) * 2007-05-22 2008-12-04 Wyeth Improved processes for making hydrazides
WO2015065954A1 (en) 2013-11-04 2015-05-07 Pfizer, Inc. Anti-efna4 antibody-drug conjugates
CA3131631A1 (en) 2013-11-04 2015-05-07 Pfizer Inc. Intermediates and methods for synthesizing calicheamicin derivatives
HRP20210292T1 (hr) 2014-04-30 2021-04-16 Pfizer Inc. Anti-ptk7 protutijelo-lijek konjugati
US10135670B2 (en) * 2014-12-22 2018-11-20 Hewlett Packard Enterprise Development Lp Response to an inoperative network device managed by a controller
US20190048073A1 (en) 2017-07-20 2019-02-14 Pfizer Inc. Anti-gd3 antibodies and antibody-drug conjugates
WO2019069931A1 (ja) 2017-10-03 2019-04-11 公立大学法人大阪府立大学 細胞培養容器、細胞の取得方法、および細胞の培養方法
CN109574870A (zh) * 2018-12-25 2019-04-05 维思普新材料(苏州)有限公司 一种酰肼的连续制备方法

Family Cites Families (35)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US623230A (en) * 1899-04-18 Rotary ore-cooler
DE2608336A1 (de) 1975-03-11 1976-09-30 Sandoz Ag Neue organische verbindungen, ihre herstellung und verwendung
US4291022A (en) * 1975-03-11 1981-09-22 Sandoz Ltd. Organic compounds
US4671958A (en) 1982-03-09 1987-06-09 Cytogen Corporation Antibody conjugates for the delivery of compounds to target sites
US4479953A (en) * 1983-08-25 1984-10-30 Merck & Co., Inc. Pyrazine aldimine compounds as antimicrobial agents
US4970198A (en) 1985-10-17 1990-11-13 American Cyanamid Company Antitumor antibiotics (LL-E33288 complex)
US4729781A (en) * 1986-08-04 1988-03-08 Sandoz Ltd. 3,6-dichloro-2-methoxybenzohydroxamic acid derivatives and use as herbicidal agents
ES2023217B3 (es) * 1986-08-04 1992-01-01 Sandoz Ag Derivados de acido benzohidroxamico.
US4939244A (en) 1987-01-30 1990-07-03 American Cyanamid Company Pseudoaglycones of LL-E33288 antibiotics
US5079233A (en) 1987-01-30 1992-01-07 American Cyanamid Company N-acyl derivatives of the LL-E33288 antitumor antibiotics, composition and methods for using the same
US5053394A (en) * 1988-09-21 1991-10-01 American Cyanamid Company Targeted forms of methyltrithio antitumor agents
US5770701A (en) 1987-10-30 1998-06-23 American Cyanamid Company Process for preparing targeted forms of methyltrithio antitumor agents
JPH05222044A (ja) 1991-10-25 1993-08-31 Eastman Kodak Co 2当量ピラゾロトリアゾールマゼンタカプラーの製造
BR9206803A (pt) * 1991-11-22 1995-05-02 Uniroyal Chemical Ltd Derivados inseticidas de fenilhidrazina
US5690904A (en) * 1993-07-12 1997-11-25 Amersham International Plc Diagnostic radiopharmaceutical compounds (That)
US5443953A (en) 1993-12-08 1995-08-22 Immunomedics, Inc. Preparation and use of immunoconjugates
US5403015A (en) * 1993-12-09 1995-04-04 Forte; Steven L. Cards and methods for playing casino 21 or blackjack
WO1996006096A1 (en) * 1994-08-23 1996-02-29 Nissan Chemical Industries, Ltd. Pyridine derivative
IT1292092B1 (it) 1997-06-05 1999-01-25 Geange Ltd Impiego di derivati eterociclici aromatici azotati nel trattamento topico di affezioni di tessuti epiteliali
JP2002527519A (ja) * 1998-10-16 2002-08-27 メルク シャープ エンド ドーム リミテッド Gaba受容体のリガンドとしてのピラゾロトリアジン誘導体
GB0008696D0 (en) * 2000-04-07 2000-05-31 Merck Sharp & Dohme Therapeutic agents
KR20040004705A (ko) * 2001-06-08 2004-01-13 시토비아 인크. 카스파제의 활성제 및 아폽토시스의 유도제로서의 치환된3-아릴-5-아릴-[1,2,4]-옥사디아졸과 유사체 및 이의 용도
DK1507556T3 (en) * 2002-05-02 2016-09-12 Wyeth Holdings Llc Calicheamicin derivative-carrier conjugates
US6803379B2 (en) * 2002-06-04 2004-10-12 Jose A. Fernandez-Pol Pharmacological agents and methods of treatment that inactivate pathogenic prokaryotic and eukaryotic cells and viruses by attacking highly conserved domains in structural metalloprotein and metalloenzyme targets
US7144876B2 (en) * 2002-12-18 2006-12-05 Cytovia, Inc. 3,5-Disubstituted-[1,2,4]-oxadiazoles and analogs as activators of caspases and inducers of apoptosis and the use thereof
ATE441417T1 (de) 2002-12-20 2009-09-15 Glaxo Group Ltd Benzoädüazepinderivate für die behandlung von neurologischen krankheiten
US7304161B2 (en) 2003-02-10 2007-12-04 Intrexon Corporation Diaclhydrazine ligands for modulating the expression of exogenous genes in mammalian systems via an ecdysone receptor complex
JP2006528694A (ja) * 2003-05-13 2006-12-21 スミスクライン ビーチャム コーポレーション ナフチリジンインテグラーゼインヒビター
PE20051029A1 (es) 2003-07-02 2005-12-07 Vertex Pharma Pirimidinas moduladoras de canales ionicos regulados por voltaje
CA2529622A1 (en) 2003-07-02 2005-01-20 Sugen, Inc. Indolinone hydrazides as c-met inhibitors
SE0302486D0 (sv) 2003-09-18 2003-09-18 Astrazeneca Ab Novel compounds
CA2563316A1 (en) * 2004-04-06 2005-10-20 Semafore Pharmaceuticals, Inc. Pten inhibitors
AR052774A1 (es) * 2004-10-08 2007-04-04 Wyeth Corp Inmunoterapia para trastornos autoinmunes
TWI404706B (zh) * 2006-01-11 2013-08-11 Actelion Pharmaceuticals Ltd 新穎噻吩衍生物
CA2687852A1 (en) * 2007-05-22 2008-12-04 Wyeth Improved processes for making hydrazides

Also Published As

Publication number Publication date
SI2155258T1 (sl) 2017-10-30
CY1119373T1 (el) 2018-02-14
US8110705B2 (en) 2012-02-07
DK2465541T3 (en) 2018-09-17
IL202242A (en) 2016-03-31
EP2465541A1 (en) 2012-06-20
CN101835494A (zh) 2010-09-15
HUE036704T2 (hu) 2018-07-30
PT2155258T (pt) 2017-10-18
US9738602B2 (en) 2017-08-22
AU2008256905A1 (en) 2008-12-04
US20130211053A1 (en) 2013-08-15
US20150099865A1 (en) 2015-04-09
CN101835494B (zh) 2012-02-15
PT2465541T (pt) 2018-10-17
AU2008256905B2 (en) 2014-05-08
ES2686019T3 (es) 2018-10-16
RU2009143524A (ru) 2011-06-27
CA2687852A1 (en) 2008-12-04
US20080312422A1 (en) 2008-12-18
KR101547705B1 (ko) 2015-08-26
CL2008001490A1 (es) 2008-07-25
CY1120592T1 (el) 2019-12-11
ES2642888T3 (es) 2017-11-20
JP2010528031A (ja) 2010-08-19
US8853451B2 (en) 2014-10-07
HK1172008A1 (zh) 2013-04-12
CN102558001B (zh) 2015-09-23
ZA200908229B (en) 2010-08-25
AR066674A1 (es) 2009-09-02
KR20100031514A (ko) 2010-03-22
EP2155258A1 (en) 2010-02-24
JP2017193584A (ja) 2017-10-26
HUE039657T2 (hu) 2019-01-28
JP5697446B2 (ja) 2015-04-08
JP2013234203A (ja) 2013-11-21
PE20090305A1 (es) 2009-03-15
WO2008147765A1 (en) 2008-12-04
PL2155258T3 (pl) 2017-12-29
TW200904784A (en) 2009-02-01
US8383857B2 (en) 2013-02-26
PA8781201A1 (es) 2008-12-18
PL2465541T3 (pl) 2018-12-31
US9227924B2 (en) 2016-01-05
EP2155258B1 (en) 2017-08-16
US20120130052A1 (en) 2012-05-24
CN102558001A (zh) 2012-07-11
MX2009012587A (es) 2010-05-14
BRPI0811140B1 (pt) 2022-08-16
HK1147736A1 (en) 2011-08-19
JP2016026219A (ja) 2016-02-12
IL202242A0 (en) 2010-06-16
DK2155258T3 (en) 2017-09-18
SI2465541T1 (sl) 2018-10-30
US20160176809A1 (en) 2016-06-23
EP2465541B1 (en) 2018-07-18

Similar Documents

Publication Publication Date Title
BRPI0813903A2 (pt) Processos para a prepração de pirazóis
DE602008003347D1 (de) Tonerverfahren
BRPI0818546A2 (pt) Misturas de enzimas para fermentação
BRPI0810482A2 (pt) Métodos de produção de proteína usando compostos antissenescência
DK3216802T3 (da) Produktionsfremgangsmåde
BRPI0906764A2 (pt) Processos
BRPI0819238A2 (pt) Métodos para a produção de caseína
BRPI0719843A2 (pt) Método para a produção de bisbenzoxazóis
BRPI0815550A2 (pt) Método para estabilizar fenilefrina
EP2120677A4 (en) IMPROVED LIGHT BALANCE PROCESS
BRPI0920621A2 (pt) processos para síntese de composto macrolidos
BRPI0922490A2 (pt) Método para produção de beta-santaleno
BRPI0816911A2 (pt) Processo para preparação de 4-aminobut-2-enolidas
BRPI0813670A2 (pt) Compostos para tratamento
PT2223114T (pt) Calibrante para imunoensaios
BRPI0813960A2 (pt) Processo para produção de biarilas
BRPI0813858A2 (pt) Método para produzir peptídeo
DK2346661T3 (da) Dannelsesfremgangsmåder
BRPI0811140A2 (pt) processos melhorados para produção de hidrazidas
BRPI0818674A2 (pt) Método para produção de anticorpos
BRPI0814261A2 (pt) Micor-organismos termofílicos para produção de etanol
EP2169142A4 (en) METHOD FOR MANUFACTURING FLOOR
FR2918983B1 (fr) Procede de preparation de dinitrotoluene
BRPI0813861A2 (pt) processos de produção de estireno
BRPI0813482A2 (pt) Processo para preparar dimetacrilatos de butanodiol

Legal Events

Date Code Title Description
B07D Technical examination (opinion) related to article 229 of industrial property law [chapter 7.4 patent gazette]
B15K Others concerning applications: alteration of classification

Free format text: "PROCEDIMENTO AUTOMATICO DE RECLASSIFICACAO. AS CLASSIFICACOES IPC ANTERIORES ERAM: A61K 47/48

Ipc: C07C 319/20 (2006.01), A61K 47/68 (2017.01), C07C

Free format text: PROCEDIMENTO AUTOMATICO DE RECLASSIFICACAO. AS CLASSIFICACOES IPC ANTERIORES ERAM: A61K 47/48; C07C 241/04; C07C 243/28; C07C 323/48.

Ipc: C07C 319/20 (2006.01), A61K 47/68 (2017.01), C07C

Ipc: C07C 319/20 (2006.01), A61K 47/68 (2017.01), C07C

B06F Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette]
B07E Notification of approval relating to section 229 industrial property law [chapter 7.5 patent gazette]
B06U Preliminary requirement: requests with searches performed by other patent offices: procedure suspended [chapter 6.21 patent gazette]
B07A Application suspended after technical examination (opinion) [chapter 7.1 patent gazette]
B09A Decision: intention to grant [chapter 9.1 patent gazette]
B16A Patent or certificate of addition of invention granted [chapter 16.1 patent gazette]

Free format text: PRAZO DE VALIDADE: 20 (VINTE) ANOS CONTADOS A PARTIR DE 20/05/2008, OBSERVADAS AS CONDICOES LEGAIS. PATENTE CONCEDIDA CONFORME ADI 5.529/DF, QUE DETERMINA A ALTERACAO DO PRAZO DE CONCESSAO.